TYK medicines

TYK Medicines, established in 2017, is a national high-tech enterprise focusing on clinical pharmaceutical R&D, with an emphasis on the development of innovative drugs for cancer and immuno-oncology. The company has built a small molecule drug design and screening platform focused on targeted therapy, a deuterated drug R&D technology platform, and a large molecule immunotherapy platform.